Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07894484
PHASE3

Lactium Premedication to Prevent Emergence Agitation

Sponsor: Tanta University

View on ClinicalTrials.gov

Summary

This biased coin sequential allocation, dose finding study will be conducted to determine the effective dose of oral lactium in 90% of children (ED90) for prevention of emergence agitation during recovery from adenotonsillectomy.

Official title: Lactium Premedication to Prevent Emergence Agitation: A Dose-Finding Study in Children Undergoing Adenotonsillectomy

Key Details

Gender

All

Age Range

3 Years - 12 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2026-11-10

Completion Date

2026-12-24

Last Updated

2026-10-27

Healthy Volunteers

No

Interventions

DRUG

Lactium

Lactium solution will be prepared by dissolving each one lentra sachet (150 mg lactium per sachet) in 50 ml of water so that each ml will contain 3 mg of lactium. Oral lactium will be initiated at a dose of 4 mg/kg in the first patient. Dose in subsequent cases will be determined by response to lactium in previous patient using absence or presence of emergence agitation as our primary outcome. A dosing interval of (1 mg/kg) will be used. If the child has no agitation, the subsequent one will receive the same dose with a probability of 0.89 or a reduced dose by 1 mg/kg with a probability of 1/9 (0.11). If the child develops agitation, the subsequent dose will be increased by 1 mg/kg with 100% certainty. If the child responds to the dose of 4 mg/kg, the dose for the next child will remain the same, since this is our minimum dose.

Locations (1)

Tanta University Hospitals

Tanta, Gharbia Governorate, Egypt